Advertisement

Topics

WuXi STA First CDMO To Support The Approval Of Innovative Drug In China

09:34 EDT 14 Jun 2018 | Pharmaceutical Processing

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo (R).
Contributed Author: 
WuXi AppTec

Original Article: WuXi STA First CDMO To Support The Approval Of Innovative Drug In China

NEXT ARTICLE

More From BioPortfolio on "WuXi STA First CDMO To Support The Approval Of Innovative Drug In China"

Advertisement
Quick Search
Advertisement
Advertisement